XML 67 R56.htm IDEA: XBRL DOCUMENT v3.19.2
Related Parties Transactions (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 27, 2019
May 12, 2019
Feb. 02, 2019
Aug. 25, 2018
Jun. 27, 2018
Apr. 12, 2017
May 06, 2016
Jan. 20, 2019
Jan. 18, 2018
Sep. 30, 2017
Jul. 24, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Jan. 26, 2017
Related Parties Transactions (Textual)                                  
Interest expenses                       $ 132,686 $ 116,802 $ 262,572 $ 223,656    
Common stock new issues                           694,219 80,000    
Due from related parties                       180,736   180,736   $ 59,477  
Collaborative Arrangement [Member]                                  
Related Parties Transactions (Textual)                                  
Common stock new issues             $ 900,000       $ 3,000,000     $ 3,000,000      
Common stock new issues, shares                           428,571      
Rgene Corporation [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital                           $ 25,025   $ 19,477  
Interest rate percentage                           0.00%   0.00%  
Due from related parties                       25,025   $ 25,025   $ 19,477  
Loan Agreement One [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date Dec. 31, 2019                                
Loan agreement, description On May 27, 2019, BioLite Taiwan entered into a loan agreement with AsiaGene for NT$100,000, equivalent to $3,225 to meet its working capital needs, pursuant to which the interest bears at 12% per annum. This loan is matured on December 31, 2019. As of June 30, 2019, the accrued interest was $31.                                
Accrued interest $ 31                                
Aggregate working capital $ 3,225                                
Interest rate percentage 12.00%                                
Loan Agreement One [Member] | NT [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital $ 100,000                                
BioFirst (Australia) Pty Ltd. [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital                           $ 40,000   $ 40,000  
Interest rate percentage                           0.00%   0.00%  
Due from related parties                       40,000   $ 40,000   $ 40,000  
BioHopeKing Corporation [Member]                                  
Related Parties Transactions (Textual)                                  
Due from related parties                       111,780   111,780    
LBG USA, Inc.[Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital                           $ 675   $ 0  
Interest rate percentage                           0.00%   0.00%  
Due from related parties                       675   $ 675    
BioLite Taiwan [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date                           Apr. 14, 2020      
Outstanding loan                           $ 94,990   65,495  
Accrued interest                           2,719   0  
Interest expenses                           2,874 0    
Aggregate working capital                           $ 94,990      
Interest rate percentage                           12.00%      
BioLite Taiwan [Member] | NT [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date                           Apr. 14, 2020      
Aggregate working capital                           $ 2,950,000      
Interest rate percentage                           12.00%      
LionGene Corporation (the "LionGene") [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital                           $ 428,099   $ 458,348  
Interest rate percentage                           0.00%   0.00%  
BriVision and BioFirst Agreement [Member]                                  
Related Parties Transactions (Textual)                                  
Total commitment     $ 693,000                           $ 950,000
Loan maturity date     Feb. 01, 2020                            
Outstanding loan                           $ 233,000   $ 692,980  
Accrued interest                           18,942   281  
Interest expenses                           $ 18,681 56,837    
Interest rate percentage     12.00%                            
BioLite Taiwan and BioFirst Agreement [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date                           May 27, 2020      
Outstanding loan                           $ 625,646   663,810  
Accrued interest                           168,370   127,976  
Interest expenses                           40,338 54,887    
Aggregate working capital                           $ 625,646      
Interest rate percentage                           12.00%      
BioLite Taiwan and BioFirst Agreement [Member] | NT [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital                           $ 19,430,000      
BioFirst [Member]                                  
Related Parties Transactions (Textual)                                  
Interest rate percentage                           0.00%      
Outstanding advance                           $ 709,444      
BioLite BVI and BioFirst Agreement [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date   May 11, 2020       May 11, 2019                      
Loan agreement, description           On April 12, 2017, BioLite BVI and BioFirst entered into a loan agreement for NT$30,000,000, equivalent to $987,134 to meet its working capital needs. Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum). BioLite BVI and BioFirst extended the loan with the same interest rate and amount for one year.                      
Outstanding loan                           987,134   981,000  
Accrued interest                           279,317   222,000  
Interest expenses                           57,317 60,113    
Aggregate working capital           $ 987,134                      
BioLite BVI and BioFirst Agreement [Member] | NT [Member]                                  
Related Parties Transactions (Textual)                                  
Aggregate working capital           $ 30,000,000                      
Asiagene Corporation [Member]                                  
Related Parties Transactions (Textual)                                  
Outstanding loan                           160,000   160,000  
Accrued interest                           22,387   12,866  
Interest expenses                           9,521 8,732    
Interest rate percentage                   0.00%              
Related party transactions, description                   Pursuant to the Investment and Equity Transfer Agreement, Everfront agreed to purchase 2,000,000 common shares of the Company owned by AsiaGene at $1.60 per share in a total amount of $3,200,000, of which $160,000 is due before September 15, 2017 and the remaining amount of $3,040,000 is due before December 15, 2017. AsiaGene also agreed to loan the proceeds to the Company for working capital purpose.              
Due from related parties                       $ 3,256   3,256    
Yuangene Corporation [Member]                                  
Related Parties Transactions (Textual)                                  
Loan maturity date               Jan. 19, 2020 Jan. 19, 2019                
Loan agreement, description                 Under the terms of the loan agreement, the loan bears interest at 1% per month (or equivalent to 12% per annum) and the Company is required to pay interest monthly to the lender.                
Outstanding loan                           50,000   50,000  
Accrued interest                           8,696   5,721  
Interest expenses                           2,975 2,696    
Aggregate working capital                 $ 50,000         $ 42,690   $ 42,690  
Interest rate percentage                           0.00%      
Keypoint Technology Ltd [Member]                                  
Related Parties Transactions (Textual)                                  
Interest expenses                           $ 10,000 0    
Interest rate percentage         8.00%                        
Related party transactions, description         On June 27, 2018, the Company issued an eighteen-month term unsecured convertible promissory note (the “Keypoint Note”) in an aggregate principal amount of $250,000 to Keypoint Technology Ltd. (“Keypoint”) (See Note 8).                        
Aggregate principal amount         $ 250,000                        
The Jiangs [Member]                                  
Related Parties Transactions (Textual)                                  
Interest rate percentage                           0.00%      
Outstanding advance                           $ 381,375      
Mr. Tsung-Shann Jiang, Ms. Shu-Ling Jiang and Ms. Mei-Ling Jiang [Member]                                  
Related Parties Transactions (Textual)                                  
Accrued interest                           $ 22,014      
Interest rate percentage                           12.00%      
Outstanding advance                           $ 795,340      
Yoshinobu Odaira [Member]                                  
Related Parties Transactions (Textual)                                  
Interest expenses                           $ 10,000 $ 0    
Interest rate percentage       8.00%                          
Related party transactions, description       The Company issued an eighteen-month term unsecured convertible promissory note (the “Odaira Note”) in an aggregate principal amount of $250,000 to Yoshinobu Odaira (“Odaira”)                          
Aggregate principal amount       $ 250,000